These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9290615)

  • 1. Treatment of visceral leishmaniasis in children with liposomal amphotericin B.
    di Martino L; Davidson RN; Giacchino R; Scotti S; Raimondi F; Castagnola E; Tasso L; Cascio A; Gradoni L; Gramiccia M; Pettoello-Mantovani M; Bryceson AD
    J Pediatr; 1997 Aug; 131(2):271-7. PubMed ID: 9290615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early efficacy of liposomal amphotericin B in the treatment of visceral leishmaniasis.
    Castagnola E; Davidson RN; Fiore P; Tasso L; Rossi G; Mangraviti S; Di Martino L; Scotti S; Cascio A; Pempinello R; Gradoni L; Giacchino R
    Trans R Soc Trop Med Hyg; 1996; 90(3):317-8. PubMed ID: 8758092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Short course treatment for visceral leishmaniasis with liposomal amphotericin B in immunocompetent patients].
    Figueras Nadal MC; García de Miguel MJ; Asensi Botet F; Velasco Bernardo R; Canals Baeza A; Ausín Aoiz I
    An Pediatr (Barc); 2003 Dec; 59(6):535-40. PubMed ID: 14636517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [First-line liposomal amphotericin B for pediatric visceral leishmaniasis in southern France].
    Minodier P; Robert S; Noël G; Blanc P; Retornaz K; Garnier JM
    Arch Pediatr; 2005 Jul; 12(7):1102-8. PubMed ID: 15964525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome).
    Davidson RN; di Martino L; Gradoni L; Giacchino R; Gaeta GB; Pempinello R; Scotti S; Cascio A; Castagnola E; Maisto A; Gramiccia M; di Caprio D; Wilkinson RJ; Bryceson AD
    Clin Infect Dis; 1996 Jun; 22(6):938-43. PubMed ID: 8783690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 6 day course of liposomal amphotericin B in the treatment of infantile visceral leishmaniasis: the Italian experience.
    Cascio A; di Martino L; Occorsio P; Giacchino R; Catania S; Gigliotti AR; Aiassa C; Iaria C; Giordano S; Colomba C; Polara VF; Titone L; Gradoni L; Gramiccia M; Antinori S
    J Antimicrob Chemother; 2004 Jul; 54(1):217-20. PubMed ID: 15150166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute renal failure due to visceral leishmaniasis by Leishmania infantum successfully treated with a single high dose of liposomal amphotericin B.
    Beltrame A; Arzese A; Camporese A; Rorato G; Crapis M; Tarabini-Castellani G; Boscutti G; Pizzolitto S; Calianno G; Matteelli A; Di Muccio T; Gramiccia M; Viale P
    J Travel Med; 2008; 15(5):358-60. PubMed ID: 19006511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of visceral leishmaniasis with a 10 day course of L-ampB-LRC (Bombay), a liposomal amphotericin B.
    Bodhe PV; Pathare AV; Kshirsagar NA; Pandya SK
    J Assoc Physicians India; 1996 Mar; 44(3):222. PubMed ID: 9251329
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and safety of single-dose liposomal amphotericin B for visceral leishmaniasis in a rural public hospital in Bangladesh: a feasibility study.
    Mondal D; Alvar J; Hasnain MG; Hossain MS; Ghosh D; Huda MM; Nabi SG; Sundar S; Matlashewski G; Arana B
    Lancet Glob Health; 2014 Jan; 2(1):e51-7. PubMed ID: 25104636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visceral leishmaniasis treated with liposomal amphotericin B.
    Catania S; Aiassa C; Tzahtzoglou S; Catania N; Tucciarone L; Antimi A; Ragni G; Clerico A
    Pediatr Infect Dis J; 1999 Jan; 18(1):73-4. PubMed ID: 9951989
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapy of visceral leishmaniasis due to Leishmania infantum: experimental assessment of efficacy of AmBisome.
    Gangneux JP; Sulahian A; Garin YJ; Farinotti R; Derouin F
    Antimicrob Agents Chemother; 1996 May; 40(5):1214-8. PubMed ID: 8723469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial.
    Sundar S; Sinha PK; Rai M; Verma DK; Nawin K; Alam S; Chakravarty J; Vaillant M; Verma N; Pandey K; Kumari P; Lal CS; Arora R; Sharma B; Ellis S; Strub-Wourgaft N; Balasegaram M; Olliaro P; Das P; Modabber F
    Lancet; 2011 Feb; 377(9764):477-86. PubMed ID: 21255828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of paediatric visceral leishmaniasis: amphotericin B or pentavalent antimony compounds?
    Kafetzis DA; Velissariou IM; Stabouli S; Mavrikou M; Delis D; Liapi G
    Int J Antimicrob Agents; 2005 Jan; 25(1):26-30. PubMed ID: 15620822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: a multi-centre trial.
    Davidson RN; Di Martino L; Gradoni L; Giacchino R; Russo R; Gaeta GB; Pempinello R; Scott S; Raimondi F; Cascio A
    Q J Med; 1994 Feb; 87(2):75-81. PubMed ID: 8153291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of liposomal amphotericin B (AmBisome) in dogs naturally infected with Leishmania infantum.
    Oliva G; Gradoni L; Ciaramella P; De Luna R; Cortese L; Orsini S; Davidson RN; Persechino A
    J Antimicrob Chemother; 1995 Dec; 36(6):1013-9. PubMed ID: 8821600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mediterranean visceral leishmaniasis in immunocompetent children. Report of two cases relapsed after specific therapy].
    Colomba C; Scarlata F; Salsa L; Frasca Polara V; Titone L
    Infez Med; 2004 Jun; 12(2):139-43. PubMed ID: 15316302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Old world Leishmania infantum cutaneous leishmaniasis unresponsive to liposomal amphotericin B treated with topical imiquimod.
    Hervás JA; Martín-Santiago A; Hervás D; Rojo E; Mena A; Rocamora V; Dueñas J
    Pediatr Infect Dis J; 2012 Jan; 31(1):97-100. PubMed ID: 21829140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trial.
    Sundar S; Agrawal G; Rai M; Makharia MK; Murray HW
    BMJ; 2001 Aug; 323(7310):419-22. PubMed ID: 11520836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-ranging studies on liposomal amphotericin B (L-AMP-LRC-1) in the treatment of visceral leishmaniasis.
    Bodhe PV; Kotwani RN; Kirodian BG; Pathare AV; Pandey AK; Thakur CP; Kshirsagar NA
    Trans R Soc Trop Med Hyg; 1999; 93(3):314-8. PubMed ID: 10492769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Visceral leishmaniasis in two children after vacation in Southern Europe].
    Castberg FC; Poulsen A; Petersen BL; Lausen B
    Ugeskr Laeger; 2013 Sep; 175(38):2193-4. PubMed ID: 24044542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.